BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3028322)

  • 1. Monitoring urine for inhaled cannabinoids.
    Moffat AC
    Arch Toxicol Suppl; 1986; 9():103-10. PubMed ID: 3028322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive inhalation of cannabis smoke.
    Law B; Mason PA; Moffat AC; King LJ; Marks V
    J Pharm Pharmacol; 1984 Sep; 36(9):578-81. PubMed ID: 6149279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke.
    Mørland J; Bugge A; Skuterud B; Steen A; Wethe GH; Kjeldsen T
    J Forensic Sci; 1985 Oct; 30(4):997-1002. PubMed ID: 2999292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids.
    Perez-Reyes M; Di Guiseppi S; Mason AP; Davis KH
    Clin Pharmacol Ther; 1983 Jul; 34(1):36-41. PubMed ID: 6305545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin.
    Law B; Mason PA; Moffat AC; Gleadle RI; King LJ
    J Pharm Pharmacol; 1984 May; 36(5):289-94. PubMed ID: 6145762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory detection of marijuana use.
    Schwartz RH; Hawks RL
    JAMA; 1985 Aug; 254(6):788-92. PubMed ID: 2989570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive cannabis smoke exposure and oral fluid testing.
    Niedbala S; Kardos K; Salamone S; Fritch D; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2004 Oct; 28(7):546-52. PubMed ID: 15516313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined high-performance liquid chromatography and radioimmunoassay method for the analysis of delta 9-tetrahydrocannabinol metabolites in human urine.
    Williams PL; Moffat AC; King LJ
    J Chromatogr; 1979 Dec; 186():595-603. PubMed ID: 232708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations on radioimmunoassay, fluorescence polarization immunoassay, and enzyme immunoassay of cannabis metabolites with gas chromatography/mass spectrometry analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine specimens.
    Weaver ML; Gan BK; Allen E; Baugh LD; Liao FY; Liu RH; Langner JG; Walia AS; Cook LF
    Forensic Sci Int; 1991; 49(1):43-56. PubMed ID: 1851715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homogeneous enzyme immunoassay for cannabinoids in urine.
    Rodgers R; Crowl CP; Eimstad WM; Hu MW; Kam JK; Ronald RC; Rowley GL; Ullman EF
    Clin Chem; 1978 Jan; 24(1):95-100. PubMed ID: 338202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity of selected compounds in the Abbott TDx cannabinoid assay.
    ElSohly MA; Jones AB; ElSohly HN
    J Anal Toxicol; 1990; 14(5):277-9. PubMed ID: 2175818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
    Johansson E; Halldin MM
    J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
    Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
    J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous quantification of major cannabinoids and metabolites in human urine and plasma by HPLC-MS/MS and enzyme-alkaline hydrolysis.
    Aizpurua-Olaizola O; Zarandona I; Ortiz L; Navarro P; Etxebarria N; Usobiaga A
    Drug Test Anal; 2017 Apr; 9(4):626-633. PubMed ID: 27341312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis].
    Goullé JP; Guerbet M
    Bull Acad Natl Med; 2014 Mar; 198(3):541-56; discussion 556-7. PubMed ID: 26427296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Passive inhalation of cannabis smoke--is it detectable?].
    Westin AA; Slørdal L
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):109-13. PubMed ID: 19151803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts.
    Grauwiler SB; Scholer A; Drewe J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):515-22. PubMed ID: 17236827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of a radioimmunoassay for cannabinoids in blood and urine.
    Teale JD; Forman EJ; King LJ; Piall EM; Marks V
    J Pharm Pharmacol; 1975 Jul; 27(7):465-72. PubMed ID: 239149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
    Moody DE; Monti KM; Crouch DJ
    J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.